ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 1015

Contribution of TNF and Type I Interferon to the Development of Persistent Post-Inflammatory Mechanical Allodynia in Arthritic Mice

Sarah Woller1, Cody Ocheltree2, Tony Yaksh1 and Maripat Corr2, 1Anesthesiology, UCSD, La Jolla, CA, 2Division of Rheumatology, Allergy, and Immunology, UCSD, La Jolla, CA

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: interferons, Mouse model, pain, toll-like receptors and tumor necrosis factor (TNF)

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Sunday, November 8, 2015

Title: Pain: Basic Aspects

Session Type: ACR Concurrent Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Male C57Bl/6 (WT) mice develop transient inflammation in response to K/BxN serum transfer and show a corresponding pain state, which persists beyond the resolution of inflammation. The current studies first examined the role of spinal cytokines, specifically TNF and IFNβ in the transition to a persistent, post-inflammatory pain state, which is mediated through Toll-like receptor (TLR) 4 signaling. Importantly, the contribution of TLR4 to pain states has been found to differ between male and female animals. Thus, our second aim was to examine whether female WT mice respond similarly to K/BxN serum transfer, and to examine whether TLR4 signaling associated spinal cytokines were involved in the development of tactile allodynia (TA) in female animals.

Methods: K/BxN sera (100μl) was injected into male and female WT, Tnf-/–, Tlr4-/–, and Ifnar1-/- mice on Days 0 and 2. Ankle width and withdrawal thresholds were examined over 28 days and then analyzed in the peak inflammatory (d3-10) and post-inflammatory (d13-18) phases. Spinal cords were collected from WT and Tlr4-/- arthritic mice and changes in gene expression were measured using qPCR.

Results: We examined spinal cords for differences in TNF and IFNβ gene transcripts on day 10 post K/BxN serum transfer, relative to day 0. IFNβ transcripts decreased in WT mice (average fold change: 0.41) and were increased in Tlr4-/- mice (average fold change: 18.84). In contrast, TNF transcripts increased in WT mice (average fold change 1.33), and remained unchanged in Tlr4-/- mice (average fold change 0.96). Next, we assessed the development of TA in male Ifnar1-/- and Tnf-/- mice. The early, inflammatory phase of pain is attenuated in Ifnar1-/- mice (1.18g threshold relative to 0.5g in WT males, p < .05); however these mice develop persistent pain while the late phase of pain is reduced in Tnf-/- mice (1.29g threshold, relative to 0.74g in WT males, p < .05).

 Next, we examined female WT mice after K/BxN serum transfer. To our surprise, female mice developed an initial tactile allodynia that is indistinguishable from males (0.72g relative to 1.97g at baseline), but do not develop a persistent pain state (post-inflammatory threshold: 1.36g, p < .05). The behavioral phenotype of female WT mice resembled that of Tlr4-/- males, and we assessed whether similar cytokine signaling contributed to the K/BxN pain phenotype. Both female Ifnar1-/- and Tnf-/- mice were indistinguishable from their male counterparts in terms of both ankle inflammation and pain (p > .05). We then determined whether TNF and IFNβ transcripts change over time (days 0, 3, 10, 18, and 28) by qPCR in male and female WT mice. Males showed a general increase in spinal TNF mRNA expression, and a decrease in IFNβ. Although the female mice also showed an increase in TNF transcripts, they had a transient decrease in IFNβ and then recovered to initial levels.

Conclusion: These results show persistent pain in male WT animals is associated with differential modulation by TNF and type I IFN. Female WT animals, however, fail to develop persistent pain, and show a recovery of IFNβ transcription indicating that co-modulation is important to prevent the development of persistent, post-inflammatory TA.


Disclosure: S. Woller, None; C. Ocheltree, None; T. Yaksh, None; M. Corr, None.

To cite this abstract in AMA style:

Woller S, Ocheltree C, Yaksh T, Corr M. Contribution of TNF and Type I Interferon to the Development of Persistent Post-Inflammatory Mechanical Allodynia in Arthritic Mice [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/contribution-of-tnf-and-type-i-interferon-to-the-development-of-persistent-post-inflammatory-mechanical-allodynia-in-arthritic-mice/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/contribution-of-tnf-and-type-i-interferon-to-the-development-of-persistent-post-inflammatory-mechanical-allodynia-in-arthritic-mice/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology